TODD-B-001

N/A

Report date: 2026/05/20 20:02:01

Base Information

Drug NameTODD-B-001
Drug Alias NameFGF21-M5TODD-B-001
ClassificationBiologics > Protein drugs > Recombinant protein
Mechanisms of ActionKlotho beta agonistsNeuroprotectantsFibroblast growth factor 21 inhibitors +[5] 
TargetsFibroblast growth factor 21Microtubule-associated protein tauKlotho beta +[4] 
Therapy Area/IndicationsNerve DegenerationMetabolic Dysfunction-Associated Steatotic Liver Disease
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritorySouth Korea
CombinationsNo
Global Highest StatusPreclinical
Highest Status in ChinaN/A
Originator CompaniesEwha Woman'S University
China Registration ClassN/A

Develop Information

Active CompaniesTODD PHARM CO LTDEwha Woman'S University
Inactive CompaniesN/A
Active IndicationsNerve DegenerationMetabolic Dysfunction-Associated Steatotic Liver Disease
Inactive IndicationsN/A

Other Information

ATC CodeN/A
Related LinksN/A